Emcure Pharmaceuticals Faces Regulatory Hurdle Following US FDA Inspection in Gujarat
Regulatory Scrutiny at Sanand Facility Emcure Pharmaceuticals Ltd. has received seven observations from the United States Food and Drug Administration (US FDA) following a recent inspection of its formulations manufacturing facility located in Sanand, Gujarat. The inspection, which concluded this week, highlights ongoing regulatory oversight regarding the company’s adherence to Current Good Manufacturing Practice (cGMP)…